These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 370341)

  • 21. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.
    O'Day DM; Ray WA; Robinson RD; Head WS
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):596-603. PubMed ID: 3549613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
    Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
    Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of cellular susceptibility to amphotericin B and of post-irradiation growth conditions on inactivation of Candida albicans by ultraviolet radiation.
    Sarachek A; Pettriess RW
    Mycopathol Mycol Appl; 1974 Nov; 54(2):205-14. PubMed ID: 4612360
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ascorbic acid on the antifungal action of amphotericin B.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    J Antimicrob Chemother; 1989 Sep; 24(3):333-7. PubMed ID: 2681119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of subinhibitory dose of amphotericin B on cell wall biosynthesis in Candida albicans.
    Mpona-Minga M; Coulon J; Bonaly R
    Res Microbiol; 1989 Feb; 140(2):95-105. PubMed ID: 2678329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action of polyene antibiotics on ribosome binding with Candida albicans membranes].
    Belousova II
    Antibiotiki; 1977 Aug; 22(8):695-9. PubMed ID: 334049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of ultrasound, the polyene antibiotic amphotericin B and their combination on the biomembranes of yeast-like fungi in the genus Candida].
    Sergeev PV; Romanenko IM; Ukhina TV; Chukaev SA
    Biull Eksp Biol Med; 1993 Oct; 116(10):391-3. PubMed ID: 8117960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance to amphotericin B and genotypic resistance to 5-fluorocytosine of serotypes A and B of Candida albicans].
    Marcelou-Kinti O; Velegraki-Abel A
    Therapie; 1988; 43(2):121-2. PubMed ID: 3043756
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of amphotericin B on the enzyme system of Candida albicans].
    Mikhaĭlova NG; Araviĭskiĭ RA
    Antibiotiki; 1977 May; 22(5):426-8. PubMed ID: 327912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC; Jacob MR; ElSohly HN; Nagle DG; Smillie TJ; Walker LA; Clark AM
    J Nat Prod; 2003 Aug; 66(8):1132-5. PubMed ID: 12932143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant enhancement of amphotericin B activity against Candida albicans.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):409-12. PubMed ID: 353923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of amphotericin B methyl ester with protoplasts of Candida albicans.
    Kerridge D; Koh TY; Johnson AM
    J Gen Microbiol; 1976 Sep; 96(1):117-23. PubMed ID: 789813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incidence of Candida albicans in infant oral materials and feces, and the sensitivity of amphotericin B to them].
    Hashimoto Y; Okuda K; Kametani H; Okumura S; Yonezawa W
    Shikwa Gakuho; 1972 Mar; 72(3):762-6. PubMed ID: 4556676
    [No Abstract]   [Full Text] [Related]  

  • 36. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J; Doyle S; Kavanagh K
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In-vitro study of the sensitivity of a strain of Candida albicans to an antibiotic-antimycotic combination (refampicin-amphotericin B)].
    Sarappa A; De Magistris A; Solli I; Varelli G; Villani A
    Ann Sclavo; 1979; 21(3):362-7. PubMed ID: 399168
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism by sterols of the action of amphotericin and filipin on the release of potassium ions from Candida albicans and Mycoplasma mycoides subsp. capri.
    Archer DB; Gale EF
    J Gen Microbiol; 1975 Sep; 90(1):187-90. PubMed ID: 1100776
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical and antigenic alterations of Candida albicans cell walls related to the action of amphotericin B sub-inhibitory doses.
    Al-Bassam T; Poulain D; Giummelly P; Lematre J; Bonaly R
    J Antimicrob Chemother; 1985 Mar; 15(3):263-9. PubMed ID: 3888942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do quinolones really augment the antifungal effect of amphotericin B in vitro?
    Overbeek BP; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1985; 11(11):745-6. PubMed ID: 3915463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.